A detailed history of Chicago Partners Investment Group LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 5,251 shares of JANX stock, worth $252,048. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,251
Holding current value
$252,048
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$35.29 - $50.26 $185,307 - $263,915
5,251 New
5,251 $238,000
Q1 2024

Apr 25, 2024

BUY
$7.93 - $49.75 $67,119 - $421,084
8,464 New
8,464 $318,000
Q3 2022

Nov 09, 2022

BUY
$10.82 - $16.84 $114,919 - $178,857
10,621 New
10,621 $181,000
Q1 2022

May 20, 2022

SELL
$13.24 - $20.24 $150,671 - $230,331
-11,380 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$15.44 - $27.32 $29,675 - $52,509
1,922 Added 20.32%
11,380 $188,000
Q3 2021

Nov 12, 2021

BUY
$20.7 - $34.69 $195,780 - $328,098
9,458 New
9,458 $204,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.